| Similar Articles |
|---|
 |
Bio-IT World
January 21, 2005 |
Defining 'Integrative Genomics' Five experts from academia and industry discuss the burgeoning field of integrative genomics.   |
Bio-IT World
Jul/Aug 2006
John Russell |
Mastering the Art of QSAR Quantitative structure activity/property relationship modeling approaches to drug design are hardly new, and increasing experience with them along with readily available computing power has expanded their use. Yet QSAR-based models remain problematic and are often poorly predictive. |
Bio-IT World
November 12, 2002
Michael Goldman |
A Virtual Pharmacopeia Computational modeling of disease pathways, organs --- even patients --- could transform drug discovery. Does salvation exist in silico? |
Bio-IT World
April 2007
Vicki Glaser |
Software Solutions for Medicinal Chemistry Driven by advances in chemical synthesis, instrumentation, and high-throughput and high-content screening technology, medicinal chemistry's transition from an art to a science is benefiting from a wealth of new software products, spanning both bio- and cheminformatics. |
Bio-IT World
Dec 2006/Jan 2007
Giacomo Bastianelli |
The Future of Predictive Biology Predictive biology, data and the integration of disparate research disciplines are key ingredients for the future of drug discovery research and healthcare. |
Bio-IT World
February 11, 2005
Salvatore Salamone |
Tackling ADME/Tox Workflow Lab techniques: Thermo's turnkey system includes a software suite to speed throughput and smooth logistics. The goal, Thermo says, is to industrialize the in vitro ADME/Tox process, a frequent bottleneck in drug development. |
Bio-IT World
October 2005 |
News Blast One Stop... New Strand... Emerging... Appointment... |
